Rosiglitazone indications

Revision as of 14:39, 20 December 2011 by Matt Pijoan (talk | contribs) (Reverted edits by AkylazGiE1 (talk) to last revision by NNethala)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Indications

AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

  • AVANDIA is indicated as monotherapy.
  • AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in adequate glycemic control. For patients inadequately controlled with a maximum dose of a sulfonylurea or metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or metformin.
  • AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin when diet, exercise, and both agents do not result in adequate glycemic control.





Adapted from the FDA Package Insert.